Stock Analysis of Concert Pharmaceuticals Inc (CNCE) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CNCE
Close 8.37
Change 0.0100 / 0.120 %
Volume 10733.30 K
Vol Change 6095.72 K / 131.44 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Good Stability


Fundamental View of Concert Pharmaceuticals Inc
PE (TTM)

-5.05

Very Poor
Price / Book

3.11

Very Poor
Price / Sales

6032.37

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

401949 K

Enterprise Value

262623 K

ROA (TTM)

-43.86

Very Poor
ROE (TTM)

-61.56

Very Poor
Net Margin (TTM)

-119465.25

Very Poor
Revenue

99.59 %

32578.00
Net Profit

99.89 %

-80051.00
Debt to Equity

0.0206

Excellent
Altman Z Score

2.56

Indecisive
Quick Ratio

0

Poor
Cash Ratio

8.88

Excellent


Highs/Lows of Concert Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week8.38 0.119 % 2.10 % 8.558.34503-Mar-2302-Mar-23
Two Week8.38 0.119 % 3.59 % 8.558.3403-Mar-2321-Feb-23
One Month8.37 0 % 3.20 % 8.558.3103-Mar-2310-Feb-23
Three Month4.86 72.22 % 6.96 % 8.554.203-Mar-2307-Dec-22
Six Months6.95 20.43 % 15.98 % 8.554.203-Mar-2307-Dec-22
One year2.78 201.08 % 24.12 % 8.552.6603-Mar-2314-Mar-22
Two year6.7 24.93 % 48.94 % 8.552.5703-Mar-2324-Feb-22
Five year22.59 62.95 % 89.41 % 8.552.5703-Mar-2324-Feb-22


Technical View of Concert Pharmaceuticals Inc
RSI

66.67

Neutral
MACD

0.208

Strong Bearish
ADX

59.91

Bullish
Super Trend

8.19

Mild Bullish
Williams %R

-78.26

Neutral
CCI

175.21

Mild Bearish


EMA 5

8.37

Bearish
EMA 15

8.34

Bullish
EMA 50

7.60

Bullish
EMA 100

6.86

Bullish
SMA 100

6.34

Bullish
SMA 200

5.99

Strong Bullish
SMA 5 / 20

8.38 / 8.37

Mild Bullish
SMA 15 / 50

8.37 / 7.49

Bullish
SMA 50 / 200

7.49 / 5.99

Strong Bullish




Charts of Concert Pharmaceuticals Inc


Returns of Concert Pharmaceuticals Inc with Peers
Period / StockCNCEACIUMODVNKTX
1 Week-0.119%-9.53%4.50%-14.22%
1 Mth0%28.30%3.09%-13.17%
3 Mth72.22%16.57%-2.94%-53.39%
6mth20.43%4.08%-27.11%77.19%
1 Year201.08%104.00%-39.97%16.43%
2 Year24.93%56.92%-68.13%-53.71%
5 Years-62.95%-29.66%-55.15%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Concert Pharmaceuticals Inc with Peers
Ratio / StockCNCEACIUMODVNKTX
PE-5.05-6.82-1.81-599.17
P/B3.112.572.09203.78
ROA-43.86-33.34-12.35-25.84
ROE-61.56-37.73-115.63-34.01
Debt To Equity0.02060.00427.080.0222
Revenue32578.00
99.59 % 		1000.00
99.97 % 		2702.26 M
7.90 % 		0
%
Net Income-80051.00
99.89 % 		-68238.00 K
3.55 % 		-206155.00 K
548.16 % 		-122329.00 K
7.46 %


Technicals of Concert Pharmaceuticals Inc with Peers
Technical / StockCNCEACIUMODVNKTX-
ADX59.9140.5122.2714.64
CMF-0.3610.0890.0461-0.104
MFI66.1666.0645.9237.12
RSI66.6752.0960.8831.94
MACD Abv SignalFalseFalseFalseFalse
Price Above 50 MATrueTrueTrueFalse-
Price Above 200 MATrueTrueFalseFalse-


About : Concert Pharmaceuticals Inc

Address : 65 Hayden Avenue, Lexington, MA, United States, 02421
Tel : 781 860 0045
URL : https://www.concertpharma.com
Code : CNCE, ISIN : US2060221056, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 13_Feb_2014
Employee Count : 64

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.


Note : All Data Generated at the End of Trading Hours (EOD Data)